- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04077086
Correcting Myopia Among Secondary School Children to Increase Academic High School Attendance Rates in Rural Communities (SWISH)
SWISH (See Well to Stay In ScHool): Randomised Trial of Spectacle Distribution to Secondary School Children With Myopia to Increase Academic High School Attendance Rates in Rural Communities)
Chinese children are some of the most short-sighted in the world, but only one in five children in poor areas who needs glasses has them. Our team has already shown in other trials that giving children free glasses leads to better grades and that free glasses have a bigger impact on grades than factors like parents' education level and the amount of money a family has. The effect on grades from glasses is greater than from other health services in school, like giving vitamins. Only about one in three children in rural China goes on to a regular, non-vocational high school. The investigators would like to show the Chinese government strong evidence of what glasses can do to help children continue their education, in order to help convince the government to carry out national programs to provide free glasses for children who need them.
Study Plan: The investigators will choose 111 middle schools at random in Liaoning, northern China, and all children in Year 1 at each school will go at random into one of two groups: either a group getting free glasses, with support from teachers to push them to wear the glasses ("Intervention") or a group getting just glasses prescriptions ("Control.") The main study outcome will be the proportion of children going on to academic (as opposed to vocational) high school, and the study is powered to detect a 10% difference in this figure between groups.The study will also assess whether children wear their glasses at school and how often they use blackboards (which disadvantage short-sighted children) vs textbooks to learn from. These other outcomes will help us to better understand the causal pathway between vision and high school attendance. We will also study the total cost of providing glasses and the teacher support to wear them per additional student attending academic high school, as well as student mental health outcomes. We will also collect data on the progression of nearsightedness. The hypothesis of this study is that providing glasses will increase academic high school attendance.
Study Overview
Detailed Description
Research question: Will providing free glasses to myopic rural Chinese students, with a teacher incentive to promote use, increase academic high school attendance?
Design: Cluster-randomised controlled trial
Rationale: Rural Chinese children have high myopia prevalence, but poor access to glasses. Our previous trials show giving free glasses significantly improves academic performance, with greater effect size than parental education or family income, equaling or exceeding other classroom-based medical interventions. Non-vocational (academic) high school attendance is only 30% in rural western China. Strong evidence of educational benefit from glasses is needed to spur adoption of national distribution programs.
Methods: Children in Year 1 at 111 randomly-selected middle schools in Liaoning, Northern China, will be randomized by school to receive free glasses and a trial-proven teacher-based incentive to promote wear (Intervention) or prescriptions only (Control). The main outcome 3 years later will be high school attendance (powered to detect 10% difference between study groups); secondary outcomes of compliance and use of near versus distance classroom learning aids will elucidate biological plausibility of a causal pathway between myopia correction and learning. Local knowledge and attitudes about myopia and spectacle use and intervention cost-effectiveness will be studied.
Statistical methods to be employed in the analysis and justification for the choice of sample size:
Adjusted- and unadjusted-comparison of the difference between study groups
Principal analyses for the main trial will include:
- Of attendance at academic high school after Year 3 of middle school (as opposed to following a vocational pathway or leaving school).
- of observed spectacle wear at un-announced examinations at school and for self-efficacy scores.
- of mental health outcomes after Year 1 year of intervention
Sample size: Assuming 120 students per school undergoing vision screening, 50% of children failing vision screening, 30% of these needing glasses, α=0.05, intra-class correlation=0.10, explained variation by covariates=0.40, difference between the groups in the main study outcome=10%, high-school attendance rate in the Control group=50%, a sample size of 111 middle-schools (55 or 56 in each group) will provide power=80%.
Loss to follow-up in our previous school-based trials in China, SWLW I and II, was approximately 4% over the course of one school year, and so our calculations here assume a loss to follow-up of 10% over 2-3 years. However, we have not adjusted for non-compliance because we will use a strict intention-to-treat analytic approach where children in schools allocated to the Intervention group will be analysed as such irrespective of compliance and because our intention is to test the policy of making free glasses available to those students who need them, rather than the effect of those students actually wearing the glasses. Further, our expected effect size is based conservatively on previous trials with compliance rates of approximately 40%, which we feel can be improved on in the current trial with teacher incentives as above.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Nathan Congdon, MD, MPH
- Phone Number: 07748751393
- Email: ncongdon1@gmail.com
Study Locations
-
-
Liaoning
-
Shenyang, Liaoning, China, 110163
- Recruiting
- He Eye Specialist Hospital
-
Contact:
- Li Meng
- Phone Number: +8613940356565
- Email: mengli@hsyk.com.cn
-
Principal Investigator:
- Sile Yu, M.D.
-
-
Xixia
-
Yinchuan, Xixia, China, 750021
- Not yet recruiting
- Ningxia University
-
Contact:
- Huiping Zhang, PhD
- Phone Number: +86 13895191039
- Email: zhp0329@sina.com
-
-
-
-
Northern Ireland
-
Belfast, Northern Ireland, United Kingdom, BT12 6BJ
- Not yet recruiting
- Centre for Public Health
-
Contact:
- Nathan Congdon, MD, MPH
- Phone Number: 8929 02890976350
- Email: ncongdon1@gmail.com
-
Contact:
- Smit Gade
- Phone Number: +7023679633
- Email: gade@goodbusinesslab.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Year 1 classes (likely age 12-13 years) at the recruited schools
- Have uncorrected (without glasses) visual acuity of ≤6/12 in both eyes;
- Refractive error meets cut-offs shown to be associated with significantly greater improvement in visual acuity when corrected (myopia ≤-0.75 diopters (D, or astigmatism (non-spherical refractive error) ≥1.00 D);
- Visual acuity can be improved to >= 6/7.5 in at least one eye with glasses.
Exclusion Criteria:
- Presence of visually-significant ocular condition besides refractive error
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention
Children at Intervention schools will receive free spectacles of a design they select, based on the child's measured refractive power and dispensed at school by the study optometrist.
Additionally, teachers (but not children) in eligible classes will be informed that if 80% spectacle compliance as measured across three separate unannounced inspections was achieved, they will be given an incentive of an conditional cash transfer.
The cash transfer will be deposited into the teacher's bank accounts directly.
|
Intervention group children in middle school Year 1 will receive spectacles in December 2024.
Assuming that the relevant effects of treatment (glasses wear) on the main study outcome are complete once examinations determining high school attendance are finished at the end of Middle School Year 3, Intervention participants will have undergone 32 months (December 2024 - July 2027) of treatment by the endpoint of the trial.
Other Names:
|
|
No Intervention: Control
Children at Control schools will receive a glasses prescription and letter to the parents informing them of the refractive status of their child, with free glasses provided only at the end of the trial.
No teacher incentive will be offered.
Service offered to the Control group exceeds standard care, in that no school-based programs of vision screening and refraction currently exist in the study area, or in most of rural China.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Academic high school attendance
Time Frame: In July following completion of Year 3 of Middle School. This occurs after 32 months of participant followup.
|
Proportion of children who continue to academic high school as opposed to vocational high school or no additional schooling, assessed by systematically contacting parents, teachers and students to ascertain enrolment status
|
In July following completion of Year 3 of Middle School. This occurs after 32 months of participant followup.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Compliance with spectacle wear
Time Frame: After 12 months of participant followup
|
Actual presence of spectacles on the child's face (rather than having glasses at school) at the time of an unannounced examination.
|
After 12 months of participant followup
|
|
Blackboard use
Time Frame: After 12 months of participant followup
|
Frequency of blackboard versus textbook use in the major subjects (Maths, Chinese, English) on a questionnaire administered to teachers, and answered as "all", "most", "about half", little" or "none" of teaching.
|
After 12 months of participant followup
|
|
Cost effectiveness of intervention.
Time Frame: At study closeout, after 32 months of participant followup
|
Calculated as ratio of incremental cost to proportion of children who continue to academic high school as opposed to vocational high school or no schooling.
Incremental cost is the difference of costs between implementation of intervention and control.
Intervention costs will comprise the screening test, glasses (including replacements) and teacher incentives.
|
At study closeout, after 32 months of participant followup
|
|
Depression and Anxiety
Time Frame: At baseline and 12 months post-treatment
|
Depression and anxiety score measured with Anxiety Stress Scale (DASS).
The score range for depression, anxiety and stress are 0-42, with higher score indicates more severe mental health problems.
|
At baseline and 12 months post-treatment
|
|
Self Esteem
Time Frame: At baseline and 12 months post-treatment
|
Self-esteem score measured with the Rosenberg Self-esteem Scale.
The scores range from 0-30, with higher scores indicate higher self-esteem.
|
At baseline and 12 months post-treatment
|
|
Emotional and behavioral problems
Time Frame: At baseline and 12 months post-treatment
|
Emotional and behavioral problems score using the Strengths and Difficulties Questionnaire (SDQ), with difficulties score ranges from 0 to 40, Prosocial scale ranges from 0-10, with higher score indicates severe mental health and behavioral problems.
|
At baseline and 12 months post-treatment
|
|
Parent-proxy quality of life
Time Frame: At baseline and 12 months post-treatment
|
Parent-proxy quality of life will be measured by using Pediatric Quality of Life Inventory™ Generic Core Scales, with scores range from 0-100.
The higher score, the better the quality of life
|
At baseline and 12 months post-treatment
|
|
Progression of Shortsightedness
Time Frame: At baseline and 12 months post-treatment
|
Progression of Shortsightedness will be measured using change in refraction over time
|
At baseline and 12 months post-treatment
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Nathan Congdon, MD, MPH, Queen's University, Belfast
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MR/S023208/1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Refractive Errors
-
Suzan A RattanCompletedRefractive Errors | Refractive SurgeryIraq
-
London School of Hygiene and Tropical MedicineBritish Council for Prevention of Blindness; Tanzanian Society for the BlindCompletedUnder- and Uncorrected Significant Refractive ErrorsTanzania
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityNot yet recruiting
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityNot yet recruiting
-
Essilor InternationalRecruitingRefractive Error | MyopiaChina
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityNot yet recruiting
-
Essilor InternationalRecruitingRefractive Error | AmetropiaUnited States
-
Chulalongkorn UniversityNot yet recruitingRefractive Errors
-
Johnson & Johnson Vision Care, Inc.CompletedRefractive ErrorUnited States
Clinical Trials on Spectacles
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityUnknown
-
Johns Hopkins UniversityNational Health and Medical Research Council, AustraliaCompletedAstigmatism | Myopia | HyperopiaChina, India
-
Essilor InternationalQueensland University of TechnologyCompleted
-
Beijing Visionly Plus Eye HospitalHigh Myopia Control Alliance (HIMALAYA); Beijing New Vision Eye HospitalRecruiting
-
Shanghai Eye Disease Prevention and Treatment CenterBrien Holden VisionRecruitingBlindness,Visual Impairment, Refractive Error, Cataract, High Myopia, AgingChina
-
CooperVision, Inc.CompletedAmetropiaUnited Kingdom
-
Ohio State UniversityNational Eye Institute (NEI)Not yet recruitingVisual Acuity | Refractive Error CorrectionUnited States
-
Avulux, Inc.Completed
-
London School of Hygiene and Tropical MedicineBritish Council for Prevention of Blindness; Tanzanian Society for the BlindCompletedUnder- and Uncorrected Significant Refractive ErrorsTanzania